BUMINATE® 25%

BUMINATE® 25% is a brand-name medication that contains Albumin (Human) and is supplied as a 25% solution. It is a blood product used in various medical settings to treat a range of conditions, particularly those involving plasma volume expansion and hypovolemia. BUMINATE® 25% is a solution containing human albumin, a protein found in blood plasma. It is used to increase blood volume and improve circulation, making it a valuable tool in the treatment of various medical conditions, particularly those requiring rapid plasma volume expansion.

Indications and Uses

BUMINATE® 25% is indicated for the following purposes:

• Plasma volume expansion in cases of hypovolemia, shock, and trauma.

• Use in burns to help maintain plasma volume and improve outcomes.

• It is employed as a therapeutic tool in the management of certain conditions like cardiopulmonary bypass surgery.

• BUMINATE® 25% is often utilized when rapid volume expansion is needed, thanks to its higher concentration compared to BUMINATE® 5%.

Dosage and Administration

The dosage of BUMINATE® 25% is typically determined by a healthcare provider based on the specific needs and medical condition of the patient. The medication is administered intravenously, and the dose and rate of administration may vary depending on individual requirements.

Contraindications

BUMINATE® 25% should not be used in individuals with known hypersensitivity to human albumin or any of its components. It is essential to discuss any allergies or potential reactions with a healthcare provider.

Adverse Effects and Side Effects

Adverse effects with BUMINATE® 25% are rare, but they may include:

• Allergic reactions, which can manifest as hives, difficulty breathing, and swelling of the face, lips, or tongue.

• Circulatory overload, which can occur if the product is administered too rapidly, leading to symptoms like shortness of breath, cough, and increased blood pressure.

• It is crucial to report any adverse effects or unusual reactions to your healthcare provider.

Storage and Shelf Life

Store BUMINATE® 25% at room temperature (20-25°C) or refrigerated (2-8°C). Protect it from excessive heat, freezing, and light. Do not use BUMINATE® 25% after the expiration date.

Packaging and Presentation

BUMINATE® 25% is typically available in bottles or vials as a sterile solution for intravenous administration.

Regulatory Information

BUMINATE® 25% is subject to regulation by health authorities to ensure its safety and efficacy. It is essential to use this medication as directed by a healthcare professional and in accordance with local regulations.

References

Always consult with your healthcare provider and refer to the official prescribing information and product labeling for the most up-to-date and comprehensive information on BUMINATE® 25%. Your healthcare provider will guide you in the proper use of this medication, monitor your progress, and tailor the treatment to your specific medical condition.